Skip to content

Low vitamin D concentrations associated with poor clinical and virological outcomes among people starting HIV therapy

People living with HIV at higher risk of cancers caused by smoking or viruses, but not all cancers

New US guidelines recommend PrEP

Daily dosing key to the efficacy of tenofovir-based HIV PrEP

New booklet from NAM: Taking your HIV treatment

New booklet from NAM: Taking your HIV treatment

No significant risk of resistance if HIV infection occurs during use of Truvada PrEP

Even moderate drinking increases risk of advanced liver fibrosis for people with HIV and HCV co-infection

Annual HIV tests for high-risk groups and one-off screening for all others could have a big impact on UK's HIV epidemic

Sofosbuvir + ribavirin is safe and effective for HCV recurrence after liver transplantation